Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 14

1.

Immunogenicities of Env glycoproteins from circulating HIV-1 isolates in China focusing on the strategy of "DNA prime plus protein boost".

Wang Z, Wang SX, Liu SY, Bao ZY, Zhuang DM, Li L, Zhang CH, Zhang L, Li JY, Lu S.

Chin Med J (Engl). 2009 Oct 5;122(19):2339-45.

PMID:
20079137
2.

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1.

Devico AL, Fouts TR, Shata MT, Kamin-Lewis R, Lewis GK, Hone DM.

Vaccine. 2002 May 6;20(15):1968-74. Review.

PMID:
11983256
3.

Combination DNA plus protein HIV vaccines.

Lu S.

Springer Semin Immunopathol. 2006 Nov;28(3):255-65. Epub 2006 Sep 21. Review.

PMID:
17021720
4.

New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview.

Girard M, Habel A, Chanel C.

C R Acad Sci III. 1999 Nov;322(11):959-66. Review.

PMID:
10646090
5.

Polyvalent AIDS vaccines.

Lu S, Grimes Serrano JM, Wang S.

Curr HIV Res. 2010 Dec;8(8):622-9. Review.

6.

Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends.

Hearty S, Conroy PJ, Ayyar BV, Byrne B, O'Kennedy R.

Expert Rev Vaccines. 2010 Jun;9(6):645-64. doi: 10.1586/erv.10.52. Review.

PMID:
20518719
7.

Receptor binding domain based HIV vaccines.

Liu H, Bi W, Wang Q, Lu L, Jiang S.

Biomed Res Int. 2015;2015:594109. doi: 10.1155/2015/594109. Epub 2015 Jan 15. Review.

8.

Prospects for a globally effective HIV-1 vaccine.

Excler JL, Robb ML, Kim JH.

Vaccine. 2015 Nov 27;33 Suppl 4:D4-12. doi: 10.1016/j.vaccine.2015.03.059. Epub 2015 Jun 20. Review.

PMID:
26100921
9.

Prospects for a Globally Effective HIV-1 Vaccine.

Excler JL, Robb ML, Kim JH.

Am J Prev Med. 2015 Dec;49(6 Suppl 4):S307-18. doi: 10.1016/j.amepre.2015.09.004. Review.

PMID:
26590431
10.

Computational design of centralized HIV-1 genes.

Arenas M, Posada D.

Curr HIV Res. 2010 Dec;8(8):613-21. Review.

PMID:
21054255
11.

Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.

Tongo M, Burgers WA.

Viruses. 2014 Oct 23;6(10):3968-90. doi: 10.3390/v6103968. Review.

12.

Approaches to preventative and therapeutic HIV vaccines.

Gray GE, Laher F, Lazarus E, Ensoli B, Corey L.

Curr Opin Virol. 2016 Mar 14;17:104-109. doi: 10.1016/j.coviro.2016.02.010. [Epub ahead of print] Review.

13.

DNA Immunization for HIV Vaccine Development.

Chen Y, Wang S, Lu S.

Vaccines (Basel). 2014 Feb 25;2(1):138-59. doi: 10.3390/vaccines2010138. Review.

14.

Neutralization-Enhancing RF Antibodies for HIV Vaccines.

Suslov KV.

Front Immunol. 2014 Dec 16;5:634. doi: 10.3389/fimmu.2014.00634. eCollection 2014. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk